Literature DB >> 24041953

Stimulatory effects of cardiotrophin 1 on atherosclerosis.

Hanae Konii1, Kengo Sato, Sayaka Kikuchi, Hazuki Okiyama, Rena Watanabe, Akinori Hasegawa, Keigo Yamamoto, Fumiko Itoh, Tsutomu Hirano, Takuya Watanabe.   

Abstract

Cardiotrophin 1 (CT-1), an interleukin-6 family cytokine, was recently shown to be expressed in the intima of early atherosclerotic lesions in the human carotid artery. CT-1 stimulates proatherogenic molecule expression in human vascular endothelial cells and monocyte migration. However, it has not been reported whether CT-1 accelerates atherosclerosis. This study was performed to examine the stimulatory effects of CT-1 on human macrophage foam cell formation and vascular smooth muscle cell migration and proliferation in vitro, and on the development of atherosclerotic lesions in apolipoprotein E-deficient (ApoE(-/-)) mice in vivo. CT-1 was expressed at high levels in endothelial cells and macrophages in both humans and ApoE(-/-) mice. CT-1 significantly enhanced oxidized low-density lipoprotein-induced foam cell formation associated with increased levels of CD36 and acyl-CoA:cholesterol acyltransferase-1 expression in human monocyte-derived macrophages. CT-1 significantly stimulated the migration, proliferation, and collagen-1 expression in human aortic vascular smooth muscle cells. Four-week infusion of CT-1 into ApoE(-/-) mice significantly accelerated the development of aortic atherosclerotic lesions with increased monocyte/macrophage infiltration, vascular smooth muscle cell proliferation, and collagen-1 content in the aortic wall. Activation of inflammasome, such as apoptosis-associated speck-like protein containing a caspase recruitment domain, nuclear factor κB, and cyclooxygenase-2, was observed in exudate peritoneal macrophages from ApoE(-/-) mice infused with CT-1. Infusion of anti-CT-1-neutralizing antibody alone into ApoE(-/-) mice significantly suppressed monocyte/macrophage infiltration in atherosclerotic lesions. These results indicate that CT-1 accelerates the development of atherosclerotic lesions by stimulating the inflammasome, foam cell formation associated with CD36 and acyl-CoA:cholesterol acyltransferase-1 upregulation in macrophages, and migration, proliferation, and collagen-1 production in vascular smooth muscle cells.

Entities:  

Keywords:  atherosclerosis; cardiotrophin 1; hypertension; macrophages; smooth muscle

Mesh:

Substances:

Year:  2013        PMID: 24041953     DOI: 10.1161/HYPERTENSIONAHA.113.01653

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  12 in total

1.  Cardiotrophin-1: A new predictor of atrial fibrillation relapses after successful cardioversion.

Authors:  Ibrahim Altun; Burak Pamukcu; Cenk Eray Yildiz; Selda Can Arkaya; Goksel Guz; Akar Yilmaz; Ahmet Kaya Bilge; Umit Mutlu Turkoglu; Kamil Adalet
Journal:  Bosn J Basic Med Sci       Date:  2015-07-23       Impact factor: 3.363

2.  Discovery of crucial cytokines associated with abdominal aortic aneurysm formation by protein array analysis.

Authors:  Yuan Li; Dan Yang; Bo Sun; Xu Zhang; Fangda Li; Zhili Liu; Yuehong Zheng
Journal:  Exp Biol Med (Maywood)       Date:  2019-10-31

3.  Vasoprotective effects of urocortin 1 against atherosclerosis in vitro and in vivo.

Authors:  Akinori Hasegawa; Kengo Sato; Remina Shirai; Rena Watanabe; Keigo Yamamoto; Kaho Watanabe; Kyoko Nohtomi; Tsutomu Hirano; Takuya Watanabe
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

4.  Potent Vasoconstrictor Kisspeptin-10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist.

Authors:  Kengo Sato; Remina Shirai; Mina Hontani; Rina Shinooka; Akinori Hasegawa; Tomoki Kichise; Tomoyuki Yamashita; Hayami Yoshizawa; Rena Watanabe; Taka-Aki Matsuyama; Hatsue Ishibashi-Ueda; Shinji Koba; Youichi Kobayashi; Tsutomu Hirano; Takuya Watanabe
Journal:  J Am Heart Assoc       Date:  2017-04-14       Impact factor: 5.501

5.  Neopterin Counters Vascular Inflammation and Atherosclerosis.

Authors:  Remina Shirai; Kengo Sato; Tomoyuki Yamashita; Maho Yamaguchi; Taisuke Okano; Kaho Watanabe-Kominato; Rena Watanabe; Taka-Aki Matsuyama; Hatsue Ishibashi-Ueda; Shinji Koba; Youichi Kobayashi; Tsutomu Hirano; Takuya Watanabe
Journal:  J Am Heart Assoc       Date:  2018-02-02       Impact factor: 5.501

6.  Adropin Contributes to Anti-Atherosclerosis by Suppressing Monocyte-Endothelial Cell Adhesion and Smooth Muscle Cell Proliferation.

Authors:  Kengo Sato; Tomoyuki Yamashita; Remina Shirai; Koichiro Shibata; Taisuke Okano; Maho Yamaguchi; Yusaku Mori; Tsutomu Hirano; Takuya Watanabe
Journal:  Int J Mol Sci       Date:  2018-04-26       Impact factor: 5.923

7.  Legumain Promotes Atherosclerotic Vascular Remodeling.

Authors:  Nana Ozawa; Yuki Sato; Yukari Mori; Hiroko Masuda; Mao Yamane; Yuka Yamamoto; Remina Shirai; Rena Watanabe; Kengo Sato; Yusaku Mori; Tsutomu Hirano; Takuya Watanabe
Journal:  Int J Mol Sci       Date:  2019-05-04       Impact factor: 5.923

8.  Potential novel biomarkers of cardiovascular dysfunction and disease: cardiotrophin-1, adipokines and galectin-3.

Authors:  Simona Hogas; Stefana C Bilha; Dumitru Branisteanu; Mihai Hogas; Abduzhappar Gaipov; Mehmet Kanbay; Adrian Covic
Journal:  Arch Med Sci       Date:  2016-03-22       Impact factor: 3.318

9.  Atheroprotective Effects of Tumor Necrosis Factor-Stimulated Gene-6.

Authors:  Rena Watanabe; Hitomi Watanabe; Yui Takahashi; Miho Kojima; Hanae Konii; Kaho Watanabe; Remina Shirai; Kengo Sato; Taka-Aki Matsuyama; Hatsue Ishibashi-Ueda; Yoshitaka Iso; Shinji Koba; Youichi Kobayashi; Tsutomu Hirano; Takuya Watanabe
Journal:  JACC Basic Transl Sci       Date:  2016-10-31

10.  Anti-Atherogenic Effects of Vaspin on Human Aortic Smooth Muscle Cell/Macrophage Responses and Hyperlipidemic Mouse Plaque Phenotype.

Authors:  Kengo Sato; Remina Shirai; Maho Yamaguchi; Tomoyuki Yamashita; Koichiro Shibata; Taisuke Okano; Yusaku Mori; Taka-Aki Matsuyama; Hatsue Ishibashi-Ueda; Tsutomu Hirano; Takuya Watanabe
Journal:  Int J Mol Sci       Date:  2018-06-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.